DE3574932D1 - Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva. - Google Patents

Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.

Info

Publication number
DE3574932D1
DE3574932D1 DE8585100307T DE3574932T DE3574932D1 DE 3574932 D1 DE3574932 D1 DE 3574932D1 DE 8585100307 T DE8585100307 T DE 8585100307T DE 3574932 T DE3574932 T DE 3574932T DE 3574932 D1 DE3574932 D1 DE 3574932D1
Authority
DE
Germany
Prior art keywords
suppressiva
anthrachinon
bisubstituted
immune
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585100307T
Other languages
English (en)
Inventor
Keith Chadwick Murdock
Frederick Emil Durr
Bosco Shang Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE3574932D1 publication Critical patent/DE3574932D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34—Amino anthraquinones
DE8585100307T 1984-02-27 1985-01-14 Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva. Expired - Fee Related DE3574932D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58354084A 1984-02-27 1984-02-27

Publications (1)

Publication Number Publication Date
DE3574932D1 true DE3574932D1 (de) 1990-02-01

Family

ID=24333530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585100307T Expired - Fee Related DE3574932D1 (de) 1984-02-27 1985-01-14 Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.

Country Status (7)

Country Link
EP (1) EP0154117B1 (de)
JP (1) JPS60208939A (de)
KR (1) KR900004646B1 (de)
AT (1) ATE48942T1 (de)
AU (1) AU581878B2 (de)
CA (1) CA1255300A (de)
DE (1) DE3574932D1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540788A (en) * 1983-07-14 1985-09-10 American Cyanamid Company Schiff bases of [(aminoalkyl or substituted aminoalkyl)amino]-9,10-anthracenediones
IL76002A0 (en) * 1984-08-03 1985-12-31 Boehringer Biochemia Srl Amino-anthracenediones-platinum complexes useful as anti-cancer compounds
EP0249632A4 (de) * 1985-12-05 1988-06-20 American Biotechnology Antitumormittel vom athracyclintyp mit l-ascorbinsäure.
DE3766984D1 (de) * 1986-03-07 1991-02-07 American Cyanamid Co Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids.
GB2245807A (en) * 1990-06-28 1992-01-08 Rank Cintel Ltd Editing of object-based animated computer graphics
ATE188870T1 (de) * 1994-10-04 2000-02-15 Lohmann Rudolf Lomapharm Lösungen von anthrachinonen zur parenteralen applikation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7708452L (sv) * 1977-07-22 1979-01-23 Allied Chem Komposition innehallande en antrakinonforening
SE445996B (sv) * 1977-08-15 1986-08-04 American Cyanamid Co Nya atrakinonderivat
US4428882A (en) * 1979-05-29 1984-01-31 American Cyanamid Company 1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones
US4278605A (en) * 1980-06-30 1981-07-14 American Cyanamid Company Heteroalkylenebisanthraquinones
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof

Also Published As

Publication number Publication date
ATE48942T1 (de) 1990-01-15
EP0154117A1 (de) 1985-09-11
KR900004646B1 (ko) 1990-07-02
EP0154117B1 (de) 1989-12-27
JPS60208939A (ja) 1985-10-21
CA1255300A (en) 1989-06-06
AU581878B2 (en) 1989-03-09
AU3915185A (en) 1985-09-05
KR850006003A (ko) 1985-09-28

Similar Documents

Publication Publication Date Title
ES549547A0 (es) Un procedimiento para la preparacion de compuesto de 2,2-difluoronucleosidos.
DE69022595T2 (de) Herstellung von kohlefaser-halbfabrikaten.
ATE22104T1 (de) Herstellung von pyrrolo-(3,4-c)-pyrrolen.
NL970032I2 (nl) DNA recombinant molecule.
DE3762616D1 (de) Hydrierung von methylendianilin zur herstellung von bis-(para-aminocyclohexyl)methanen.
DE3684737D1 (de) Herstellung von ethern aus linearen olefinen.
JPS6420227A (en) Oxazolidone-containing epoxy resin
DE3674055D1 (de) Verfahren zur herstellung von 1,3,5-triazintrionen.
HK19595A (en) Fluoxetine useful for the treatment of diabetes
GR3003933T3 (de)
DK461787D0 (da) Fremgangsmaade til selektivt at foroege maengdeforholdet mellem enkelte hovedkomponenter af antibiotikum a/16686-kompleks
DE3574932D1 (de) Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.
ATE78239T1 (de) Verfahren zur herstellung von zeolithen.
IT8820808A0 (it) Poliammine parzialmente sostituite con 4,6 bis[ n,n bis(2,2,6,6 tetrametil 4piperidil)ammino]-1,3,5-triazin-2-il.
DE3669938D1 (de) Ebenes gleitstueck mit anschraegung.
IT8948551A0 (it) Procedimento per la produzione di analgesia in mammiferi.
DE3681853D1 (de) Verfahren zur herstellung von sauerstoff enthaltenden decalinderivaten.
DE3667287D1 (de) Verfahren zur herstellung von bis(dialkylphenyl)pentaerythritoldiphosphiten.
DE3750349T2 (de) Anordnung zur Herstellung von Dünnschichten.
DE3888543T2 (de) Zusammensetzungen zur herstellung von gasdurchlässigen kontaktlinsen.
ATE57520T1 (de) Verfahren zur herstellung von bromierten bisphenolen.
DE3851523T2 (de) Verfahren zur Herstellung von Thiotepa.
DE3879351D1 (de) Verfahren zur herstellung von bis(4-amino-phenyl)hexafluoropropan.
DE3577183D1 (de) Verwendung eines diamins zur herstellung eines erythrozyten-weichmachers.
DE3269137D1 (en) Process for preparing purified bis (3,5-dialkyl-4-hydroxyphenyl) sulfone

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee